Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...
It combines the company’s InPen smart insulin pen with its Simplera continuous glucose monitor (CGM), a disposable, all-in-one device. The MDI system is poised to be the first on the market to ...
Provided image of Medtronic's Smart MDI system combines its InPen smart insulin pen with continuous glucose monitor to help users calculate insulin doses.